CAPTRUST FINANCIAL ADVISORS - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 342 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,008,595
+284.8%
26,403
+473.2%
0.00%
+300.0%
Q4 2022$262,082
+52.4%
4,606
+18.0%
0.00%0.0%
Q2 2022$172,000
+27.4%
3,902
+15.6%
0.00%0.0%
Q1 2022$135,000
+3.1%
3,374
+3.9%
0.00%0.0%
Q4 2021$131,000
+11.0%
3,247
+12.0%
0.00%0.0%
Q3 2021$118,000
+0.9%
2,898
+12.1%
0.00%0.0%
Q2 2021$117,000
+8.3%
2,585
-0.1%
0.00%0.0%
Q1 2021$108,000
+30.1%
2,588
+32.4%
0.00%0.0%
Q4 2020$83,000
+84.4%
1,955
+15.0%
0.00%0.0%
Q3 2020$45,000
-4.3%
1,7000.0%0.00%0.0%
Q2 2020$47,000
+80.8%
1,7000.0%0.00%0.0%
Q3 2019$26,000
-10.3%
1,7000.0%0.00%0.0%
Q2 2019$29,000
+7.4%
1,7000.0%0.00%0.0%
Q1 2019$27,000
+8.0%
1,7000.0%0.00%0.0%
Q4 2018$25,000
-19.4%
1,7000.0%0.00%0.0%
Q3 2018$31,0001,7000.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Third Security, LLC 19,829,337$266,308,00010.60%
BB BIOTECH AG 6,929,832$93,068,0002.95%
SECTORAL ASSET MANAGEMENT INC 2,671,051$35,872,0001.64%
Sterling Global Strategies LLC 22,000$295,0001.63%
Lombard Odier Asset Management (USA) Corp 1,061,547$14,257,0001.24%
PYRRHO CAPITAL MANAGEMENT, LP 90,000$1,209,0001.04%
IRIDIAN ASSET MANAGEMENT LLC/CT 8,184,003$109,911,0000.93%
Bellevue Asset Management AG 246,000$3,304,0000.54%
Convergence Investment Partners, LLC 251,748$3,381,0000.39%
Rhenman & Partners Asset Management AB 172,000$2,310,0000.37%
View complete list of HALOZYME THERAPEUTICS INC shareholders